181 related articles for article (PubMed ID: 29170639)
1. A Cell Line for Detection of Botulinum Neurotoxin Type B.
Rust A; Doran C; Hart R; Binz T; Stickings P; Sesardic D; Peden AA; Davletov B
Front Pharmacol; 2017; 8():796. PubMed ID: 29170639
[TBL] [Abstract][Full Text] [Related]
2. Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.
Fabris F; Šoštarić P; Matak I; Binz T; Toffan A; Simonato M; Montecucco C; Pirazzini M; Rossetto O
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457172
[TBL] [Abstract][Full Text] [Related]
3. Universal and specific quantitative detection of botulinum neurotoxin genes.
Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC
BMC Microbiol; 2010 Oct; 10():267. PubMed ID: 20961439
[TBL] [Abstract][Full Text] [Related]
4. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
5. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
6. The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent.
Gray B; Cadd V; Elliott M; Beard M
Toxicol In Vitro; 2018 Apr; 48():255-261. PubMed ID: 29373835
[TBL] [Abstract][Full Text] [Related]
7. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
[TBL] [Abstract][Full Text] [Related]
8. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Q Rev Biophys; 1995 Nov; 28(4):423-72. PubMed ID: 8771234
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay.
Fernández-Salas E; Wang J; Molina Y; Nelson JB; Jacky BP; Aoki KR
PLoS One; 2012; 7(11):e49516. PubMed ID: 23185348
[TBL] [Abstract][Full Text] [Related]
11. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
12. Progress in cell based assays for botulinum neurotoxin detection.
Pellett S
Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357
[TBL] [Abstract][Full Text] [Related]
13. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
Pellett S; Tepp WH; Johnson EA; Sesardic D
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
[TBL] [Abstract][Full Text] [Related]
14. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
15. SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E.
Bak N; Rajagopal S; Stickings P; Sesardic D
Toxins (Basel); 2017 Jul; 9(7):. PubMed ID: 28726719
[TBL] [Abstract][Full Text] [Related]
16. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
17. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.
Schenke M; Schjeide BM; Püschel GP; Seeger B
Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344847
[TBL] [Abstract][Full Text] [Related]
19. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
20. Differences in the multiple step process of inhibition of neurotransmitter release induced by tetanus toxin and botulinum neurotoxins type A and B at Aplysia synapses.
Poulain B; De Paiva A; Deloye F; Doussau F; Tauc L; Weller U; Dolly JO
Neuroscience; 1996 Jan; 70(2):567-76. PubMed ID: 8848160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
